Analgesics, Antipyretics & NSAIDs
The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.
Paracetamol, ibuprofen and acetylsalicylic acid are the three non-opioid analgesics named in section 2.1 of the WHO Model List. All three are antipyretic and analgesic; paracetamol is explicitly not recommended for anti-inflammatory use, because the benefit is not proven.
At a glance
- All three Model List non-opioid analgesics — paracetamol, ibuprofen, aspirin — are in our range.
- Paracetamol is listed as an antipyretic and analgesic, not an anti-inflammatory.
- WHO warns against offering both 120 mg/5 mL and 125 mg/5 mL paracetamol liquids on one market.
- Ibuprofen is not indicated below three months of age per the Model List.
- We supply 21 analgesic products across six dosage forms, including paediatric weight-band presentations.
01What the published guidance says
Every statement below is drawn from WHO or MSF published material and linked to its source. We summarise; we do not reproduce. Statements marked as our own are commercial positions, not clinical guidance.
The Model List specifies the exact presentations
Section 2.1 of the 24th WHO Model List (2025) lists acetylsalicylic acid (suppository 50–150 mg; tablet 100–500 mg), ibuprofen (oral liquid 100 mg/5 mL; tablet 200, 400 and 600 mg) and paracetamol (oral liquid 120 mg/5 mL or 125 mg/5 mL and 250 mg/5 mL; suppository 100 and 250 mg; tablet 250, 325 and 500 mg; dispersible tablet 100 and 250 mg).
A strength-confusion warning that matters commercially
The Model List itself warns that the presence of both 120 mg/5 mL and 125 mg/5 mL paracetamol oral liquid strengths on the same market would cause confusion in prescribing and dispensing and should be avoided. Country programmes should therefore settle on one strength.
Paracetamol is an antipyretic and analgesic — not an anti-inflammatory
The Model List carries a footnote stating paracetamol is not recommended for anti-inflammatory use due to lack of proven benefit to that effect. Marketing copy that positions paracetamol as an anti-inflammatory is inconsistent with the WHO listing.
Age limits worth building into your labelling
Ibuprofen is not indicated in children less than three months of age according to the Model List. Paediatric paracetamol dosing should follow national formulary weight bands.
Fever control is part of severe-disease management
MSF guidance on severe malaria directs paracetamol in the event of high fever only — a reminder that in febrile illness the antipyretic is supportive care, not the disease treatment.
02Products in this therapeutic group
Each entry links to its full specification page.
| Product | Dosage form | Presentation notes | Detail |
|---|---|---|---|
| Paracetamol syrup 500mg/15ml total 100ml | Syrup | View Paracetamol syrup 500mg/15ml total 100ml → | |
| Paracetamol oral solution containing 1000mg | Syrup | View Paracetamol oral solution containing 1000mg → | |
| Paracetamol oral solution 325mg per 10ml | Syrup | View Paracetamol oral solution 325mg per 10ml → | |
| Paracetamol Oral Suspension 160mg per 5mL | Suspension | View Paracetamol Oral Suspension 160mg per 5mL → | |
| Ibuprofen Oral Suspension 100mg/5mL | Suspension | Pediatric Fever & Pain | View Ibuprofen Oral Suspension 100mg/5mL → |
| Paracetamol Injection 500mg/5mL | Injection | IV Analgesic Antipyretic | View Paracetamol Injection 500mg/5mL → |
| Diclofenac Sodium Injection 3ml:75mg | Injection | View Diclofenac Sodium Injection 3ml:75mg → | |
| Lysine Acetylsalicylate Injection 900mg | Injection | View Lysine Acetylsalicylate Injection 900mg → | |
| Piroxicam Injection 10mg/ml | Injection | View Piroxicam Injection 10mg/ml → | |
| Paracetamol 500mg Effervescent Tablets | Tablet | View Paracetamol 500mg Effervescent Tablets → | |
| Paracetamol 500mg Tablets | Tablet | View Paracetamol 500mg Tablets → | |
| Methamizole 500mg Tablets | Tablet | View Methamizole 500mg Tablets → | |
| Ibuprofen 100mg Tablets | Tablet | View Ibuprofen 100mg Tablets → | |
| Copara compound tablets with Paracetamol 500mg | Tablet | View Copara compound tablets with Paracetamol 500mg → | |
| Aspirin Tablets 300mg | Tablet | View Aspirin Tablets 300mg → | |
| Mefenamic Capsules 250mg | Capsule | View Mefenamic Capsules 250mg → | |
| Diclofenac Sodium 50mg Capsules | Capsule | View Diclofenac Sodium 50mg Capsules → | |
| Paracetamol Suppository 150mg | Suppository | Rectal Analgesic & Antipyretic for Fever | View Paracetamol Suppository 150mg → |
| Naproxen Suppositories 250mg | Suppository | View Naproxen Suppositories 250mg → | |
| Indomethacin Suppository 100mg | Suppository | NSAID for Severe Pain, Fever & Inflammation | View Indomethacin Suppository 100mg → |
| Ibuprofen Suppository 50mg | Suppository | Pediatric NSAID for Fever & Mild Pain Relief | View Ibuprofen Suppository 50mg → |
21 products in this group · part of 186 finished dosage forms across 14 therapeutic areas.
03Specifying your order
The five things worth stating on a purchase order for this group, so the quotation comes back right first time.
Single liquid strength
Tell us which paracetamol oral-liquid strength your formulary has adopted. We will supply one strength only, avoiding the mix-up the Model List warns about.
Dosage form
Tablet, dispersible, effervescent, capsule, oral suspension, syrup, suppository or injection — each has a different lead time and pack format.
Paediatric presentation
State the weight band and whether you need a graduated dosing device packaged with the bottle.
Effervescent composition
Specify the sodium content and any sugar or sugar-alcohol requirement, since these matter in some patient groups.
Suppository strength
Confirm the strength, as the Model List specifies 100 mg and 250 mg while national formularies often add intermediates.
04How we supply it
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
Every route
Tablets, dispersible and effervescent tablets, capsules, oral suspensions and syrups, suppositories, and injectable paracetamol, diclofenac, piroxicam and lysine acetylsalicylate.
Paediatric focus
Weight-band oral suspensions and low-strength suppositories, including the paediatric ibuprofen and paracetamol presentations used in fever protocols.
Single-strength discipline
We will supply one paracetamol oral-liquid strength per market on request, to avoid the confusion the Model List warns about.
Documentation
COA with assay, dissolution and related substances; stability data; dossier and registration support.
05Safety, labelling & regulatory notes
Points worth carrying into your tender, label review or clinical briefing.
- Confirm which paracetamol oral-liquid strength your national formulary has adopted and specify a single strength on the purchase order.
- Avoid positioning paracetamol as an anti-inflammatory in promotional material.
- Diclofenac is not listed on the WHO Model List — stock it only where your national essential medicines list includes it.
- Aspirin in febrile children carries a Reye's syndrome risk in many national labels. Confirm the local prescribing information restricts paediatric use accordingly.
06Questions buyers ask
6 answers covering specification, documentation and regulatory questions for this group.
Which strengths of paracetamol oral liquid should we order?
Do you supply paracetamol suppositories?
Is diclofenac on the WHO Essential Medicines List?
Can you supply sustained-release or combination analgesics?
Do you supply paediatric paracetamol in weight-band dosing?
Can you supply paracetamol injection?
07Related therapeutic areas
Adjacent groups you may want to combine on one purchase order.
Request a quotation for Analgesics & NSAIDs
Send us the products, strengths and pack sizes you need, together with the destination country, and we will return a quotation with the documentation package and lead time. Registration support documents are provided with every order.
Request a quotation →